The
research report “Tubeless Insulin Pump
Market Size By Component (Pod/Patch, Remote,
Others), By Distribution Channel (Hospitals, Pharmacies, e-Commerce, Others),
Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, France, China,
Japan, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi
Arabia), Technology Development, Competitive Landscape & Forecast, 2017 –
2024”
by Global Market Insights, Inc. says, Tubeless Insulin Pump Market size is set
to exceed USD 2 billion by 2024.
Rising
number of diabetic and obese patients coupled with introduction of advanced
pump will serve as high impact rendering factors for the tubeless insulin pump
market growth. Advent of new technologies in continuous glucose monitoring
without the need for daily insulin injection doses will stimulate business
growth over the forecast years. Growing adoption of minimally invasive insulin
delivery methods should improve patient compliance.
Request for a sample of
this research report - https://www.gminsights.com/request-sample/detail/2032
Inadequate
reimbursement coverage and high long-term cost associated with tubeless insulin
pump will hamper its adoption in emerging economies. Compliance to insulin
therapy may reduce owing to high maintenance therapy cost.
The
pods/patches tubeless insulin pump market should witness more than 20% CAGR
over the coming years. Regular replacement of pods and high usage frequency
will drive the escalated demand for these products.
Tubeless
insulin pump remote should grow in parallel with the pods segment. Although the
replacement rate of remotes is not as high as that of pods, their initial
capital requirement is higher. Increasing sales of new tubeless insulin pump
will fuel the significant growth of the remote market.
Distribution
of tubeless insulin pump through e-commerce platforms has become the most
popular medium. In 2016, e-commerce held the market share of over 50%, valuing
more than USD 250 million. This online platform will witness a significant growth
over the forecast period.
Browse key
industry insights spread across 130 pages with 66 market data tables & 8
figures & charts from this 2017 report Tubeless
Insulin Pump Market in detail along with the table of contents at:
Distribution
through hospitals is less preferred medium because of the high cost of tubeless
insulin pump. However, many private hospitals have recently started offering
tubeless insulin pump at affordable prices, augmenting the industry growth of
the tubeless insulin pump market.
U.S.
tubeless insulin pump market valued over USD 200 million in 2016 and
anticipated to grow significantly over the coming years. Switching of insulin
pump user from tubed to tubeless should be the major growth rendering factor.
Moreover, increasing adoption of tubeless pump by first time users will fuel
regional industry growth.
Germany
tubeless insulin pump market accounted for more than 20% of overall regional
revenue share, owing to increasing number of diabetic patients and advanced
healthcare system. Growing adoption of advanced technology will drive rapid
industry grow over the forecast years.
Japan
tubeless insulin pump market accounted for largest regional revenue share owing
to its growing trend to adopt advanced technology. Rising per capita income of
diabetic patients and high healthcare expenditure will promote tubeless insulin
pump market growth.
China
should witness lucrative growth in terms of revenue over the forecast period.
Factors such as economic growth, large unaddressed diabetic population, rising
disposable income, and improving healthcare facilities will propel business
growth.
Brazil
tubeless insulin pump market is projected to grow at 18% CAGR of over the
forecast period. Availability of tubeless insulin pump in recent years will
stimulate steady business expansion.
Some
of the companies operating in tubeless insulin pump market are Insulet
Corporation, Johnson & Johnson, Medtrum Technologies, Roche Holding,
Cellnovo Group, Spring Health Solution, Debiotech, CeQur, Valeritas, and Abbott
Diabetes Care.
New
product launches and geographical expansion will primarily drive the industry.
Key industry participants will strive to strengthen their position in this
competitive market by adoption these strategies.
Browse Related Reports:
Antidiabetics Market Size By
Product (Insulin [Rapid Acting, Long Acting, Premixed, Short Acting,
Intermediate Acting], Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas,
GLP-1 Agonist, Meglitinides, DPP-4 Inhibitors, SGLT-2, Thiazolodinediones), By
Application (Type I Diabetes, Type II & Other), Industry Analysis Report,
Regional Outlook, Application Potential, Price Trends, Competitive Market Share
& Forecast, 2016 – 2023
About Global Market Insights:
Global
Market Insights, Inc., headquartered in Delaware, U.S., is a global market
research and consulting service provider; offering syndicated and custom
research reports along with growth consulting services. Our business
intelligence and industry research reports offer clients with penetrative insights
and actionable market data specially designed and presented to aid strategic
decision making. These exhaustive reports are designed via a proprietary
research methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and biotechnology.
Contact
Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
No comments:
Post a Comment